{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:47:31Z","timestamp":1755218851758,"version":"3.43.0"},"reference-count":29,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Pre-eclampsia is a common and serious pregnancy complication. This review describes that low-dose acetylsalicylic acid can reduce the risk of preterm pre-eclampsia in high-risk pregnant women if treatment is started before the 16th week of pregnancy. A new screening algorithm can already, in the first trimester of pregnancy, predict an individual woman\u2019s risk of developing pre-eclampsia by combining a series of biophysical and biochemical markers with maternal risk factors. The screening has been validated internationally and in Denmark. In 2025, a national implementation project will be initiated to evaluate the effectiveness of a change in screening strategy in Denmark.<\/jats:p>","DOI":"10.61409\/v11240762","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:28:54Z","timestamp":1746757734000},"page":"1-8","source":"Crossref","is-referenced-by-count":1,"title":["First-trimester screening for pre-eclampsia"],"prefix":"10.61409","author":[{"given":"Iben","family":"Riishede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette Ladeg\u00e5rd","family":"Skov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puk","family":"Sandager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Tabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Rode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Kvist","family":"Ekelund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Brown MA, Magee LA, Kenny LC et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24-43. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10803","DOI":"10.1161\/HYPERTENSIONAHA.117.10803"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Andersen MF, Rode L, Riishede I, Tabor A, Ekelund CK. Lavdosisacetylsalicylsyre til forebyggelse af pr\u00e6eklampsi. Ugeskr L\u00e6ger 2024;186:V10230682. https:\/\/doi.org\/10.61409\/V10230682","DOI":"10.61409\/V10230682"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287-293.e1. https:\/\/doi.org\/10.1016\/j.ajog.2017.11.561","DOI":"10.1016\/j.ajog.2017.11.561"},{"key":"ref3","unstructured":"Christensen M, Godtfredsen AC, Olawi FM et al. Hypertension og pr\u00e6eklampsi, 2024. https:\/\/static1.squarespace.com\/static\/5467abcce4b056d72594db79\/t\/65eb70c2b6c6115ca2e4f192\/1709928643647\/Pr%C3%A6eklampsi++og+Hypertension+2024+.pdf (15. okt 2024)"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Rode L, Ekelund CK, Riishede I et al. Prediction of preterm pre-eclampsia according to NICE and ACOG criteria: descriptive study of 597 492 Danish births from 2008 to 2017. Ultrasound Obstet Gynecol. 2021;58(4):561-567. https:\/\/doi.org\/10.1002\/uog.23693","DOI":"10.1002\/uog.23693"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"O'Gorman N, Wright D, Syngelaki A et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1-103.e12. https:\/\/doi.org\/10.1016\/j.ajog.2015.08.034","DOI":"10.1016\/j.ajog.2015.08.034"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Tan MY, Syngelaki A, Poon LC et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2018;52(2):186-195. https:\/\/doi.org\/10.1002\/uog.19112","DOI":"10.1002\/uog.19112"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rolnik DL, Wright D, Poon LCY et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):492-495. https:\/\/doi.org\/10.1002\/uog.18816","DOI":"10.1002\/uog.18816"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"O'Gorman N, Wright D, Poon LC et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756-760. https:\/\/doi.org\/10.1002\/uog.17455","DOI":"10.1002\/uog.17455"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Poon LC, Shennan A, Hyett JA et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019;145 Suppl 1(Suppl 1):1-33. https:\/\/doi.org\/10.1002\/ijgo.12802","DOI":"10.1002\/ijgo.12802"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Guizani M, Valsamis J, Dutemeyer V et al. First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the fetal medicine foundation-algorithm. Fetal Diagn Ther. 2018;43(4):266-273. https:\/\/doi.org\/10.1159\/000477934","DOI":"10.1159\/000477934"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Chaemsaithong P, Pooh RK, Zheng M et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019;221(6):650.e1-650.e16. https:\/\/doi.org\/10.1016\/j.ajog.2019.09.041","DOI":"10.1016\/j.ajog.2019.09.041"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Lobo GAR, Nowak PM, Panigassi AP et al. Validation of fetal medicine foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population. J Matern Fetal Neonatal Med. 2019;32(2):286-292. https:\/\/doi.org\/10.1080\/14767058.2017.1378332","DOI":"10.1080\/14767058.2017.1378332"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Tan MY, Wright D, Syngelaki A et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51(6):743-750. https:\/\/doi.org\/10.1002\/uog.1903","DOI":"10.1002\/uog.1903"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Riishede I, Rode L, Sperling L et al. Pre\u2010eclampsia screening in Denmark (PRESIDE): national validation study. Ultrasound Obstet Gynecol. 2023;61(6):682-690. https:\/\/doi.org\/10.1002\/uog.26183","DOI":"10.1002\/uog.26183"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Rolnik DL, Wright D, Poon LC et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613-622. https:\/\/doi.org\/10.1056\/NEJMoa1704559","DOI":"10.1056\/NEJMoa1704559"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Wright D, Rolnik DL, Syngelaki A et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol. 2018;218(6):612.e1-612.e6. https:\/\/doi.org\/10.1016\/j.ajog.2018.02.014","DOI":"10.1016\/j.ajog.2018.02.014"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Crombag NMTH, Lamain-de Ruiter M, Kwee A et al. Perspectives, preferences and needs regarding early prediction of preeclampsia in Dutch pregnant women: a qualitative study. BMC Pregnancy and Childbirth. 2017;17(1):12. https:\/\/doi.org\/10.1186\/s12884-016-1195-2","DOI":"10.1186\/s12884-016-1195-2"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Gerdes SMB, Ekelund CK, Rode L et al. Motivation towards first trimester screening for preeclampsia among pregnant women in Denmark: a cross-sectional questionnaire study. Acta Obstet Gynecol Scand. 2023;102(11):1531-1540. https:\/\/doi.org\/10.1111\/aogs.14632","DOI":"10.1111\/aogs.14632"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Nik\u010devi\u0107 AV, Sacchi C, Marino C et al. Psychological impact and women's evaluation of the first-trimester pre-eclampsia screening and prevention: ASPRE trial. Int J Environ Res Public Health. 2023;20(7):5418. https:\/\/doi.org\/10.3390\/ijerph20075418","DOI":"10.3390\/ijerph20075418"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Silang K, Tomfohr-Madsen L, Maxey C et al. First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety. AJOG Glob Rep. 2023;3(2):100205. https:\/\/doi.org\/10.1016\/j.xagr.2023.100205","DOI":"10.1016\/j.xagr.2023.100205"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Park F, Deeming S, Bennett N, Hyett J. Cost-effectiveness analysis of a model of first-trimester prediction and prevention of preterm pre-eclampsia compared with usual care. Ultrasound Obstet Gynecol. 2021;58(5):688-697. https:\/\/doi.org\/10.1002\/uog.22193","DOI":"10.1002\/uog.22193"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Garcia AD, Devlieger R, Redekop K et al. Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium. Pregnancy Hypertens. 2021;25:219-224. https:\/\/doi.org\/10.1016\/j.preghy.2021.06.012","DOI":"10.1016\/j.preghy.2021.06.012"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ortved D, Hawkins TLA, Johnson JA et al. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2019;53(2):239-244. https:\/\/doi.org\/10.1002\/uog.19076","DOI":"10.1002\/uog.19076"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Nzelu D, Palmer T, Stott D et al. First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study. BJOG. 2024;131(2):222-230. https:\/\/doi.org\/10.1111\/1471-0528.17598","DOI":"10.1111\/1471-0528.17598"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Beernink RHJ, Scherjon SA, Cremers TIFH, van Asselt ADI. Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands. J Reprod Immunol. 2023;160:104141. https:\/\/doi.org\/10.1016\/j.jri.2023.104141","DOI":"10.1016\/j.jri.2023.104141"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Strijbos LTM, Hendrix MLE, Al-Nasiry S et al. Which first-trimester risk assessment method for preeclampsia is most suitable? A model-based impact study. Am J Obstet Gynecol MFM. 2023;5(7):100974. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100974","DOI":"10.1016\/j.ajogmf.2023.100974"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Mewes JC, Lindenberg M, Vrijhoef HJM. Cost-effectiveness analysis of implementing screening on preterm pre-eclampsia at first trimester of pregnancy in Germany and Switzerland. PLoS One. 2022;17(6):e0270490. https:\/\/doi.org\/10.1371\/journal.pone.0270490","DOI":"10.1371\/journal.pone.0270490"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Foster AB, Park F, Hyett J. Do first-trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre-term preeclampsia: a systematic review and meta-analysis. Prenat Diagn. 2023;43(7):950-958. https:\/\/doi.org\/10.1002\/pd.6394","DOI":"10.1002\/pd.6394"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:23:31Z","timestamp":1754483011000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V11240762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":29,"URL":"https:\/\/doi.org\/10.61409\/v11240762","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}